Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Medicare's drug benefit has given a shot in the arm to pharmaceutical companies and insurers, whose revenue is climbing thanks to government subsidies for prescription medicine. What's happened so far: Drugmakers including GlaxoSmithKline and Pfizer reported higher-than-expected sales and profit in the second quarter, with some of the momentum coming from Medicare. Meanwhile, membership rolls of big insurers, including UnitedHealth Group and Humana, are mushrooming as Medicare beneficiaries sign up for drug plans. Drug companies -- which successfully thwarted price-control attempts -- are reaping the rewards of more seniors and disabled people getting access to their medications. British drugmaker GlaxoSmithKline's second-quarter net income grew 14 percent over the same quarter last year due in part to strong Medicare drug sales. Merck & Co., Schering Plough, Wyeth, Roche and Pfizer ... all exceeded analysts' expectations, reflecting sales boosts from the program. In the first three months of the benefit, brand-name drug prices rose 4 percent, according to a report from the AARP. WellPoint Inc., the nation's largest insurer, reported second-quarter profit gains of 34 percent. UnitedHealth ... posted quarterly profit gains of 26 percent. Humana reported earlier this week its second-quarter profit increased 9.9 percent and revenue jumped 52 percent over the same quarter last year, due in large part to a surge in Medicare membership. The insurer expects annual revenue to grow by 50 percent.

Note: This article fails to mention who pays for all these profits -- our tax dollars. To understand the degree of corruption in the pharmaceutical industry, read a two-page summary by one of the most respected MDs in the U.S. at http://www.WantToKnow.info/healthcoverup

In 2002, [a] German-born molecular geneticist startled the scientific world by creating the first live, fully artificial virus in the lab. It was a variation of the bug that causes polio. The virus was made wholly from nonliving parts, using equipment and chemicals on hand. The most crucial part, the genetic code, was picked up for free on the Internet. The new technology opens the door to new tools for defeating disease and saving lives. But today, in hundreds of labs worldwide, it is also possible to transform common intestinal microbes into killers. Or to resurrect bygone killers, such the 1918 influenza. New techniques...allow the creation of synthetic viruses in mere days. Hardware unveiled last year by a Harvard genetics professor can churn out synthetic genes by the thousands, for a few pennies each. The U.S. Centers for Disease Control and Prevention has declined so far to police the booming gene-synthesis industry. "It would be possible -- fully legal -- for a person to produce full-length 1918 influenza virus or Ebola virus genomes," said Richard H. Ebright, a biochemist and professor at Rutgers University. "It is also possible to advertise and to sell the product." Five years after the Sept. 11 attacks, the federal government budgets nearly $8 billion annually -- an 18-fold increase since 2001 -- for the defense of civilians against biological attack. Billions have been spent to develop and stockpile new drugs, most of them each tied to a single, well-known bioterrorism threat, such as anthrax. If successful, [each] drug is a solution for just one disease threat out of a list that is rapidly expanding to include man-made varieties.

Note: The government research lab at Fort Detrick, Maryland, has been secretly developing this technology for decades. For serious questions on the role of secret government projects in deadly disease creation and dissemination, see http://www.WantToKnow.info/resources#emerging or click here.

Drug companies are accused today of endangering public health through widescale marketing malpractices, ranging from covertly attempting to persuade consumers that they are ill to bribing doctors and misrepresenting the results of safety and efficacy tests on their products. In a report that charts the scale of illicit practices by drug companies in the UK and across Europe, Consumers International - the world federation of consumer organisations - says people are not being given facts about the medicines they take because the companies hide the marketing tactics on which they spend billions. "Irresponsible marketing practices form a serious, persistent and widespread problem among the entire pharmaceutical industry," says the report, which analyses the conduct of 20 of the biggest companies. Scandals such as the withdrawal of Vioxx ... show that unethical drug promotion is a consumer concern. Merck withdrew the drug in September 2004, but allegedly knew it could increase the chances of heart attacks and strokes from 2000 and has been accused of manipulating study results to play down the risk. More than 6,000 lawsuits have been filed against the company in the United States by people who claim they suffered heart attacks as a result of the drug. There is no room for complacency when drug companies spend twice as much on marketing as on research...but do not publish information on their drug promotion practices.

The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people. The windfall, which by some estimates could be $2 billion or more this year, is a result of the transfer of millions of low-income people into the new Medicare Part D drug program that went into effect in January. Under that program...the prices paid by insurers, and eventually the taxpayer, for the medications given to those transferred are likely to be higher than what was paid under the federal-state Medicaid programs. Analysts expect it to generate hundreds of millions of additional dollars this year for the drug companies. Drugs tend to be cheaper under the Medicaid programs because the states are the buyers and by law they receive the lowest available prices for drugs. But in creating the federal Part D program, Congress -- in what critics saw as a sop to the drug industry -- barred the government from having a negotiating role. The windfall for the drug makers was made possible by a provision of the 2003 Medicare law that exempts Part D drugs from "best price" rebates that the drug makers have been required to give to the state Medicaid programs. Those rebates are meant to make sure that state Medicaid agencies pay no more than the best prices drug companies offer to any big commercial insurer. Now, under Part D, all sorts of price deals will be negotiated by dozens of Medicare drug plans. The prices will be reported to Medicare, but under a provision of the law pushed by industry lobbyists, they will otherwise be kept secret.

For the second time in two months, The Journal of the American Medical Association says it was misled by researchers who failed to reveal financial ties to drug companies. The latest incident, disclosed in letters to the editor and a correction in Wednesday's journal, involves a study showing that pregnant women who stop taking antidepressants risk slipping back into depression. Most of the 13 authors have financial ties to drug companies including antidepressant makers, but only two of them revealed their ties when the study was published in February.

Note: To understand how the drug companies manipulate results and even exert tremendous influence over the U.S. Congress, see http://www.WantToKnow.info/healthcoverup

For years the life science companies...have argued that genetically modified food is the next great scientific and technological revolution in agriculture. Nongovernmental organizations...have been cast as the villains in this unfolding agricultural drama...accused of continually blocking scientific and technological progress because of...opposition to genetically modified food. Now, in an ironic twist, new, cutting-edge technologies have made gene splicing and transgenic crops obsolete. The new frontier is called genomics, and the new agricultural technology is called marker-assisted selection, or MAS. This technology offers a sophisticated method to greatly accelerate classical breeding. A growing number of scientists believe that MAS...will eventually replace genetically modified food. Environmental organizations that have long opposed genetically modified crops are guardedly supportive of MAS technology. Rapidly accumulating information about crop genomes is allowing scientists to [use] MAS to locate desired traits in other varieties of a particular food crop, or its relatives that grow in the wild. Then they cross-breed those related plants with the existing commercial varieties to improve the crop. With MAS, the breeding of new varieties always remain within a species, thus greatly reducing the risk of environmental harm and potential adverse health effects associated with genetically modified crops. If properly used as part of a much larger systemic and holistic approach to sustainable agricultural development, MAS technology could be the right technology at the right time in history.

Note: For astonishing information on the dangers to your health of genetically modified foods, see the most popular document on our website in recent months at http://www.WantToKnow.info/deception10pg

Northfield Lab's experimental blood substitute Polyheme is currently in randomized phase III clinical trials recruiting patients without informed consent all over the country. At one point, it was being tested in as many as 27 cities; it is still being tested in 23 hospitals in 20 cities. With the FDA's approval, Northfield Lab has recruited hospitals to participate in the trial study with exemption from informed consent requirements on study participants. Although Northfield Lab claims that extensive information on the study has been made public, a vast majority of the general public has never heard of the trial.

Federal health authorities have signed a two-year deal to help states buy more than half a billion dollars worth of the antiviral drug Tamiflu as a hedge against a pandemic of deadly avian influenza, but there is a catch: States will have to pay for three-quarters of it. Under terms of the deal negotiated with Roche by the Department of Health and Human Services, the states can order up to 31 million packets of Tamiflu -- each containing a 10-pill course of treatment -- for a total cost of $596 million over the next two years. The Bush administration announced late Friday that it had contracted with Swiss drugmaker Roche Laboratories Inc. to supply Tamiflu for stockpiles in all 50 states. The federal government, meanwhile, plans to build its own centralized stockpile. The plan is to have enough antiviral drug in state and federal warehouses by December 2008 to treat 81 million people. Tamiflu is considered by scientists to be the first line of defense against the H5N1 strain of bird flu. The disease is currently confined primarily to chickens, ducks and some wild waterfowl, but researchers fear it could mutate into a form that spreads easily among humans.

Note: No mention is made here that Donald Rumsfeld has already made millions from sales of Tamiflu, and that he was on the board of the company that developed the drug. Many top researchers also believe there is little chance of avian flu mutating. Why are we spending hundreds of millions of dollars to combat a virus which has not even mutated yet? To verify these and other vital facts, see http://www.WantToKnow.info/avianflu

A 15-month inquiry by a top House Democrat has found that enforcement of the nation's food and drug laws declined sharply during the first five years of the Bush administration. For instance, the investigation found, the number of warning letters that the Food and Drug Administration issued to drug companies, medical device makers and others dropped 54 percent, to 535 in 2005 from 1,154 in 2000. The seizure of mislabeled, defective or dangerous products dipped 44 percent. The research found no evidence that such declines could be attributed to increased compliance with regulations. Investigators at the F.D.A. continued to uncover about the same number of problems at drug and device companies as before...but top officials of the agency increasingly overruled the investigators' enforcement recommendations. The investigation found that by almost every measure, enforcement actions had significantly declined from 2000 to 2005. Dr. Sidney M. Wolfe, director of the Health Research Group at the watchdog organization Public Citizen, noted that the agency now received about $380 million a year in fees from drug makers. "The public," Dr. Wolfe said, "is getting the kind of F.D.A. that the industry is paying for them to get."

Note: For lots more on collusion between government and the medical industry, see our Health Information Center at http://www.WantToKnow.info/healthinformation

Government nutrition researcher [Dr. Mark Levine] has published new evidence that suggests vitamin C can work like chemotherapy - only better. But so far, he hasn't been able to interest cancer experts in conducting the kind of conclusive studies that, one way or the other, would advance treatment. "If vitamin C is useful in cancer treatment, that's wonderful. If it's not, or if it's harmful, that's fine, too," said Levine, a Harvard-educated physician at the National Institute of Diabetes and Digestive and Kidney Diseases. The distinction between oral and intravenous is crucial. The body automatically gets rid of extra C through urine. Levine's lab has shown that, at high concentrations, the vitamin is toxic to many types of cancer cells in lab dishes. But to get that much C into the body before it's eliminated, it must be put directly into the blood. Five out of nine types of cancer cells that were put in simulated body-cavity fluid died when concentrated ascorbate or peroxide was added to the dish. And the best part: This same lethal marinade had no effect on healthy cells. "Interest is definitely growing," said Kenneth Bock, physician and president of the American College for Advancement in Medicine, an alternative-medicine society that teaches ascorbate infusion protocols. The American Cancer Society and the American Association of Clinical Oncologists warn patients against high-dose C, as do leading cancer centers such as the University of Pennsylvania's and Memorial Sloan-Kettering.

Note: If the above link does not work, the article is also available on the website of the San Diego Union-Tribune. For why this is not making major headlines in the news, click here and here.

At a congressional hearing, Sen. Barbara Boxer (D-Calif.) said the Environmental Protection Agency had designated as confidential the details of about 140 Superfund sites where toxic exposure remained uncontrolled. The secret data included information about how much money and time it would take to clean up the dangerous sites, including one site where the EPA predicted it would take 26 years to close off access to toxics. "This isn't a question of left or right," Boxer said, waving a document marked "Privileged" by EPA officials to prevent its release to the public. "This is a question of right and wrong." The Superfund program was created almost three decades ago in response to environmental disasters such as Love Canal, a neighborhood in Niagara Falls, N.Y., where chemical contamination forced the removal of 800 families and led to $200 million in remediation costs. Those sites are areas where the public still faces some possible exposure to toxic substances -- such as a building near buried radioactive waste that was not surrounded by a fence. A skateboard park built over the site, however, was protected by a layer of dirt. One Republican-sponsored bill moving through Congress would limit data available on toxic substances released into communities, and the U.S. Army Corps of Engineers has blocked information on flooding dangers in Florida.

Note: Major toxic hazards would seem to be a direct threat to the security of those living around the hazards, yet the EPA is keeping these records secret. If you read the entire article, you will see how the LA Times is framing this as a Democrat vs. Republican issue, when it is in fact about public health and safety.

With waived-consent studies becoming more prevalent, critics question whether the public understands how they work and whether test subjects get adequate protection. [A] trial, which is reported in today's Journal of the American Medical Association (JAMA), was halted because a device called the AutoPulse, which was used to revive cardiac-arrest victims, failed to save more lives than when rescuers performed cardiopulmonary resuscitation. Patients in these types of studies...are treated under a broad federal rule that allows researchers to test emergency treatments on patients with specific, life-threatening medical conditions without their explicit consent as long as they remain under close watch of independent reviewers. Studies have included large, multi-city, randomized trials, which scientists consider the gold standard for medical research. The [PolyHeme] trial has raised concern among some ethicists and alarm in Congress, where Sen. Charles Grassley, R-Iowa, chairman of the Finance Committee, is conducting an investigation. Grassley is concerned that people who live in the 19 states where PolyHeme is being tested have had inadequate notice about the trial. The FDA requires that community input be sought in the regions around test sites. "It is outrageous that, for all intents and purposes, the FDA allowed a clinical trial to proceed, which makes every citizen in the United States a potential 'guinea pig,' without providing a practical, informative warning to the public," Grassley wrote in a letter to the FDA in February.

In a public health emergency, suspected victims would no longer have to give permission before experimental tests could be run to determine why they're sick, under a federal rule published Wednesday. Privacy experts called the exception unnecessary, ripe for abuse and an override of state informed-consent laws. Health care workers will be free to run experimental tests on blood and other samples taken from people who have fallen sick as a result of a bioterrorist attack, bird flu outbreak, detonation of a dirty bomb or any other life-threatening public health emergency, according to the rule issued by the Food and Drug Administration. The rule took effect Wednesday but remains subject to public comment until Aug. 7. The FDA said it published the rule without first seeking comments because it would hinder the response to an outbreak of bird flu or other public health emergency.

A lawsuit filed Wednesday seeks to force the U.S. government to conduct mandatory reviews of genetically engineered foods and require labeling of such foods once they are approved. The Center for Food Safety's suit against the Food and Drug Administration comes after years of lobbying by environmental and consumer groups for more stringent regulation and labeling of biotech crops. Genetically modified crops, such as soybeans, corn, and canola, are grown widely throughout the United States, and the world leader in development and marketing of the gene-altered crops is...Monsanto. Yet the United States requires no independent testing of these crops or the food products they are used in, does not mandate what data companies must submit for review, and does not require that foods that contain biotech crops be labeled. CFS and more than fifty consumer and environmental groups, filed a legal petition with the FDA in March 2000, asking the agency to adopt a more rigorous approach to biotech food regulation, but the CFS said Wednesday that the FDA had ignored the petition. At various times over the last several years, different scientists, including some within the FDA, have warned that altering the genetic makeup of a food plant by inserting genes from one organism into another...could trigger unexpected food allergies, create toxins in food, or spread antibiotic-resistant disease. CFS said the tests that exposed that potential hazard have not been conducted on any of the genetically modified foods currently marketed.

Note: Many laboratory animals died in scientific tests of GM foods, yet this news has yet to be reported in the major media. If you want to understand the risks involved with the ever-increasing numbers of genetically modified organisms in the food you eat, don't miss: http://www.WantToKnow.info/deception10pg

What are the essentials of President Bush's plan for bird flu pandemic preparedness? The plan calls for a $7.1 billion total expenditure. The president proposes that $2 billion of this would be devoted to stockpiling antiviral medications and 20 million doses of an experimental vaccine against the bird flu strain H5N1. $2.7 billion would go toward vaccine research and upgrading our methods of vaccine manufacture. Federal dollars would be invested in an international flu-surveillance network, and federal funding to state and local public health agencies would be boosted by $100 million. Critics of the plan say that far too little is designated for the state and local agencies or for fighting bird flu in Asia, where it is currently (only $251 million would be spent overseas). Critics also have complained that the plan doesn't provide for improving the hospital infrastructure for disaster response. According to Dr. Irwin Redlener ... at Columbia University: "Less than seven percent of that budget could be construed as going towards anything that would help bolster a very ailing hospital system in the United States. Which in fact would be the only recourse that we would have if, in fact, we're dealing with a race against time. And if it becomes real that we get a pandemic prior to the development of sufficient capacity to contain, to vaccinate and to treat with specific antivirals, then all we have left is a health and hospital system ... we'll find that we don't have sufficient isolation beds, intensive care beds, ventilators, et cetera, et cetera."

Note: Over $4 billion was gifted to big Pharma for drugs and vaccines based largely on fear mongering. And after the big scare around the avian flu, less than 200 people died from it. So all of that money was pure profit for the pharmaceuticals. For more along these lines, see concise summaries of deeply revealing news articles on bird and swine flu from reliable major media sources.

American researchers say that their study supports the findings of Andrew Wakefield, the discredited gastroenterologist who raised fears that the measles, mumps and rubella injection might be causing autism. His research, published in The Lancet in 1998, detected traces of the measles virus in the guts of 12 children with autism. The latest study, led by Arthur Krigsman, of New York University School of Medicine, involved 275 children. Serious intestinal inflammations were found in some of the autistic children and biopsies of gut tissue were performed on 82 of them. Of these, 70 are said to have shown evidence of the measles virus, which so far has been confirmed in 14 cases by more stringent DNA tests. Steve Walker, assistant professor at Wake Forest University Medical Centre, North Carolina, who analysed the gut samples, said the work mirrored Dr Wakefield's study. All the children involved were diagnosed with autism and had come to Dr Krigsman and Dr Walker seeking help for symptoms of serious digestive problems for which no explanation could be found. Mainstream science has repeatedly examined the theory of a link between MMR and autism and found no evidence to back it.

Note: Though "mainstream science" has allegedly found no links, many other scientific and media sources have found strong evidence of a link. See http://www.WantToKnow.info/060215vaccinesmercurydangers

The American Diabetes Association...privately enlisted an Eli Lilly & Co. executive to chart its growth strategy. The National Alliance on Mental Illness...lobbies for treatment programs that also benefit its drug-company donors. The National Gaucher Foundation...gets nearly all its revenue from one drugmaker, Genzyme Corp. Many patient groups and drug companies maintain close, multimillion-dollar relationships while disclosing limited or no details about the ties. An Inquirer examination of six groups, each a leading advocate for patients in a disease area, found that the groups rarely disclose such ties when commenting or lobbying about donors' drugs. Combined, the six received at least $29 million from drug companies last year. The amount ranged from 2 percent to 7 percent of revenue at the Arthritis Foundation, to 89 percent to 91 percent at the much smaller National Gaucher Foundation. The funding usually comes from the companies' marketing or sales divisions, not charity offices. Grants often rise with promotional spending as a drug hits the market and fall when sales ebb. Donations from Merck and Pfizer Inc. to the Arthritis Foundation more than doubled, to at least $1.65 million combined, in 2000 as they launched Vioxx and Celebrex. Merck explicitly wove the foundation into sales strategies. In 2000-2001, the American Diabetes Association did not disclose an unusual gift from Lilly: a lent executive, Emerson "Randy" Hall Jr., who moved into its Alexandria, Va., headquarters and coached it on growth strategies, all paid by Lilly.

Note: If you want to understand how the huge pharmaceutical industry influences what you know about their drugs, this article is a must read. You may first want to read a riveting two-page summary of an exposé by the former editor-in-chief of the New England Journal of Medicine, who details major collusion and corruption in the pharmaceutical industry at http://www.WantToKnow.info/healthcoverup

Drug companies fund a growing number of the studies in leading psychiatric journals, and drugs fare much better in these company-funded studies than in trials done independently or by competitors, researchers reported Wednesday. About 57% of published studies were paid for by drug companies in 2002, compared with 25% in 1992, says psychiatrist Igor Galynker of Beth Israel Medical Center in New York City. His team looked at clinical research in four influential journals: American Journal of Psychiatry, Archives of General Psychiatry, Journal of Clinical Psychiatry and Journal of Clinical Psychopharmacology. In the report, released at the American Psychiatric Association meeting in Toronto, reviewers did not know who paid for the studies they evaluated, Galynker says. There were favorable outcomes for a medication in about: eight out of 10 studies paid for by the company that makes the drug; five out of 10 studies done with no industry support; three out of 10 studies done by competitors of the firm making the drug. As drug companies increasingly fund research that yields favorable outcomes for their drugs, there may be a built-in bias because journals are reluctant to publish studies with negative or inconclusive findings.

Note: To learn more about the astonishing profits and power of the major drug companies, read our concise summary of a major insider's research at http://www.WantToKnow.info/healthcoverup

It's a quiet mountain community, but some residents claim something's happening in the sky that's making them sick. Mystery clouds and unusual contrails ... Is it a weather experiment on a massive scale? In a Channel 4 News investigation, Paul Moyer looks into why some say the government is manipulating the weather. Watch: Video Report. References: U.S. Senate Committee testimony on Weather Modification, Owning the Weather in 2025 (U.S. Airforce), California Skywatch (Rosalind Peterson), Alpenhorn News Stories.

Note: In certain circles, the phenomenon of chemtrails is hotly debated. Very rarely does it make the news. The fact that NBC in LA is reporting on this is big. Don't miss the video news report available free online at: http://www.nbc4.tv/video/9265818/detail.html.

A horrifying ... disease is affecting thousands of people in the Bay Area, along the Gulf Coast and in Florida. Though some doctors have claimed the malady is psychosomatic, other scientists are making headway unraveling the mystery of Morgellons Disease. Former Oakland A's pitcher Billy Koch has it. And so do his wife and their three children. It started in Oakland four years ago. Koch saved 44 games and was the top reliever in the major leagues. Within two years -- at age 29 -- Billy Koch was out of baseball, partly because of the uncontrollable muscle twitching that went on for months at a time and often kept up him up all night. The disease is characterized by slow-healing skin lesions that often extrude small, dark filaments, especially after bathing. More than 3,000 families nationwide [report] these same unexplained symptoms. Oklahoma State University Professor Randy Wymore was the first scientist to conduct research on this disconcerting disease. He says it's the biggest mystery he's ever been involved in. The UC Davis-trained physiologist is leading a medical team at Oklahoma State University in Tulsa. With cooperation from the Centers for Disease Control and Prevention, Wymore's team is studying Bay Area patients and others from around the country. His first finding disputes the frequent diagnosis of delusions. He says the filaments are not an external contamination. Instead, they are a substance that materializes somehow inside the body, apparent artifacts of something infectious. More results are expected soon. And Wymore says skin problems are not the worst symptoms. He says a neurotoxin or microorganism may disturb muscle control and memory. "The neurological effects are the much more severe, life altering and much more dangerous of the conditions."

Note: To watch an intriguing five-minute video of the above story on KTVU, click here.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.